BamSEC and AlphaSense Join Forces
Learn More

Novavax Inc.

NASDAQ: NVAX    
Share price (12/20/24): $8.70    
Market cap (12/20/24): $1.394 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from S-3ASR 56 pages Novavax, Inc. and the Bank of New York Mellon Trust Company, N.A., as Trustee Indenture Dated as of [ ], [ ]
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 118 pages Novavax, Inc., as Issuer, and the Bank of New York Mellon Trust Company, N.A., as Trustee Indenture Dated as of December 20, 2022 5.00% Convertible Senior Notes Due 2027
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 2 pages Novavax, Inc. Series a Convertible Preferred Stock
12/34/56
EX-4.3
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-3 2 pages Indenture or similar
12/34/56
EX-4.1
from 8-K 104 pages Novavax, Inc. and the Bank of New York Mellon Trust Company, N.A. as Trustee Indenture Dated as of January 29, 2016 3.75% Convertible Senior Notes Due 2023
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant to Purchase Shares of Common Stock of Novavax, Inc
12/34/56
EX-4
from 8-K 1 page March 20, 2006 Rahul Singhvi President / Chief Executive Officer Novavax, Inc. 508 Lapp Road Malvern, Pa 19355 Dear Mr. Singhvi
12/34/56
EX-4
from 8-K 2 pages Rahul Singhvi President / Chief Executive Officer Novavax, Inc. 508 Lapp Road Malvern, Pa 19355 Dear Mr. Singhvi
12/34/56
EX-4.7
from S-3 29 pages Registration Rights Agreement
12/34/56
EX-4.8
from S-3 19 pages Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 63 pages Rights Agreement by and Between Novavax, Inc. and Equiserve Trust Company, N.A., as Rights Agent Dated as of August 8, 2002
12/34/56
EX-4
from SC 13D/A ~10 pages Convertible Note No. 2
12/34/56
EX-4
from SC 13D ~20 pages Registration Rights Agreement
12/34/56
EX-4.5
from S-3 ~50 pages Form of Subscription Agreement
12/34/56
EX-4.2
from S-3 ~50 pages Certificate of Designations
12/34/56